Ischaemic preconditioning in transplantation and major resection of the liver

British Journal of Surgery

Volumn 92, Issue 5, 2005, Pages 528-538

  Banga, N R ^a   Homer Vanniasinkam, S ^b   Graham, A ^c   Al Mukhtar, A ^a   White, S A ^a   Prasad, K R ^a  

^a ST JAMES S UNIVERSITY HOSPITAL   (United Kingdom)

^b LEEDS GENERAL INFIRMARY   (United Kingdom)

^c UNIVERSITY OF BRADFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATE; CD11B ANTIGEN; CYTOKINE; INTERCELLULAR ADHESION MOLECULE 1; L SELECTIN; NITRIC OXIDE; PADGEM PROTEIN;

CELL DAMAGE; CYTOKINE RELEASE; INJURY SCALE; KUPFFER CELL; LIVER ISCHEMIA; LIVER RESECTION; LIVER TRANSPLANTATION; MEDLINE; PRIORITY JOURNAL; REPERFUSION INJURY; REVIEW;

ADENOSINE TRIPHOSPHATE; CELL ADHESION MOLECULES; CELL DEATH; CYTOKINES; GENE EXPRESSION; HUMANS; ISCHEMIC PRECONDITIONING; LIVER; LIVER DISEASES; LIVER TRANSPLANTATION; MICROCIRCULATION; PHOSPHOTRANSFERASES; REPERFUSION INJURY;

EID: 18844421571     PISSN: 00071323     EISSN: None     Source Type: Journal    
DOI: 10.1002/bjs.5004     Document Type: Review

References (123)

1. Rosen HR, Martin P, Goss J, Donovan J, Melinek J, Rudich S et al. Significance of early aminotransferase elevation after liver transplantation. Transplantation 1998; 65: 68-72.
2. Huguet C, Gavelli A, Chieco PA, Bona S, Harb J, Joseph JM et al. Liver ischemia for hepatic resection: where is the limit? Surgery 1992; 111: 251-259.
3. Yoshizumi T, Yanaga K, Soejima Y, Maeda T, Uchiyama H, Sugimachi K. Amelioration of liver injury by ischaemic preconditioning. Br J Surg 1998; 85: 1636-1640.
4. Roth S, Li B, Rosenbaum PS, Gupta H, Goldstein LM, Maxwell KM et al. Preconditioning provides complete protection against retinal ischemic injury in rats. Invest Ophthalmol Vis Sci 1998; 39: 777-785.
5. Glazier S, O'Rourke D, Graham D, Welsh F. Induction of ischemic tolerance following brief focal ischemia in rat brain. J Cereb Blood Flow Metab 1994; 14: 545-553.
6. Clavien PA, Harvey PR, Strasberg SM. Preservation and reperfusion injuries in liver allografts. An overview and synthesis of current studies. Transplantation 1992; 53: 957-978.
7. Lemasters JJ, Thurman RG. Reperfusion injury after liver preservation for transplantation. Annu Rev Pharmacol Toxicol 1997; 37: 327-338.
8. Serracino-Inglott F, Habib NA, Mathie RT. Hepatic ischemia-reperfusion injury. Am J Surg 2001; 181: 160-160.
9. Lentsch AB, Kato A, Yoshidome H, McMasters KM, Edwards MJ. Inflammatory mechanisms and therapeutic strategies for warm hepatic ischemia/reperfusion injury. Hepatology 2000; 32: 169-173.
10. Carden DL, Granger DN. Pathophysiology of ischaemia-reperfusion injury. J Pathol 2000; 190: 255-266.
11. Jaeschke H. Molecular mechanisms of hepatic ischemia-reperfusion injury and preconditioning. Am J Physiol Gastrointest Liver Physiol 2003; 284: G15-G26.
12. Belghiti J, Noun R, Malafosse R, Jagot P, Sauvanet A, Pierangeli F et al. Continuous versus intermittent portal triad clamping for liver resection: a controlled study. Ann Surg 1999; 229: 369-375.
13. Huguet C, Gavelli A, Bona S. Hepatic resection with ischemia of the liver exceeding one hour. J Am Coll Surg 1994; 178: 454-458.
14. Behrns KE, Tsiotos GG, DeSouza NF, Krishna MK, Ludwig J, Nagorney DM. Hepatic steatosis as a potential risk factor for major hepatic resection. J Gastrointest Surg 1998; 2: 292-298.
15. Strasberg SM, Howard TK, Molmenti EP, Hertl M. Selecting the donor liver: risk factors for poor function after orthotopic liver transplantation. Hepatology 1994; 20: 829-838.
16. Howard TK, Klintmalm GB, Cofer JB, Husberg BS, Goldstein RM, Gonwa TA. The influence of preservation injury on rejection in the hepatic transplant recipient. Transplantation 1990; 49: 103-107.
17. Baron P, Sindram D, Higdon D, Howell D, Gottfried M, Tuttle-Newhall J et al. Prolonged rewarming time during allograft implantation predisposes to recurrent hepatitis C infection after liver transplantation. Liver Transplant 2000; 6: 407-412.
18. Selzner M, Clavien PA. Fatty liver in liver transplantation and surgery. Semin Liver Dis 2001; 21: 105-113.
19. Wanner G, Ertel W, Muller P, Hofer Y, Leiderer R, Menger M et al. Liver ischemia and reperfusion induces a systemic inflammatory response through Kupffer cell activation. Shock 1996; 5: 34-40.
20. Jaeschke H, Farhood A. Neutrophil and Kupffer cell-induced oxidant stress and ischaemia-reperfusion injury in rat liver. Am J Physiol 1991; 260: G355-G362.
21. Suzuki S, Toledo-Pereyra L. Interleukin-1 and tumour necrosis factor production as the initial stimulants of liver ischaemia and reperfusion injury. J Surg Res 1994; 57: 253-258.
22. Colletti L, Cortis A, Lukacs N, Kunkel S, Green M, Strieter R. Tumor necrosis factor up-regulates intercellular adhesion molecule 1, which is important in the neutrophil-dependent lung and liver injury associated with hepatic ischaemia and reperfusion in the rat. Shock 1998; 10: 182-191.
23. Jaeschke H, Farhood A, Smith CW. Neutrophils contribute to ischemia/reperfusion injury in rat liver in vivo. FASEB J 1990; 4: 3355-3359.
24. Vollmar B, Menger MD, Glasz J, Leiderer R, Messmer K. Impact of leukocyte-endothelial cell interaction in hepatic ischemia-reperfusion injury. Am J Physiol 1994; 267: G786-G793.
25. Jaeschke H, Smith CW. Cell adhesion and migration. III. Leukocyte adhesion and transmigration in the liver vasculature. Am J Physiol 1997; 273: G1169-G1173.
26. Kobayashi A, Imamura H, Isobe M, Matsuyama Y, Soeda J, Matsunaga K et al. Mac-1 (CD11b/CD18) and intercellular adhesion molecule-1 in ischemia-reperfusion injury of rat liver. Am J Physiol Gastrointest Liver Physiol 2001; 281: G577-G585.
27. Yadav SS, Howell DN, Gao W, Steeber DA, Harland RC, Clavien PA. L-selectin and ICAM-1 mediate reperfusion injury and neutrophil adhesion in the warm ischemic mouse liver. Am J Physiol 1998; 275: G1341-G1352.
28. Zibari GB, Brown MF, Burney DL, Granger N, McDonald JC. Role of P-selectin in the recruitment of leukocytes in mouse liver exposed to ischemia and reperfusion. Transplant Proc 1998; 30: 2327-2330.
29. Granger DN, Kubes P. The microcirculation and inflammation: modulation of leukocyte-endothelial cell adhesion. J Leukoc Biol 1994; 55: 662-675.
30. Kubes P, Payne D, Woodman RC. Molecular mechanisms of leukocyte recruitment in postischemic liver microcirculation. Am J Physiol Gastrointest Liver Physiol 2002; 283: G139-G147.
31. Singh I, Zibari GB, Zizzi H, Granger DN, Cruz L, Gonsales E et al. Anti-P-selectin antibody protects against hepatic ichemia-reperfusion injury. Transplant Proc 1998; 30: 2324-2326.
32. Yadav SS, Howell DN, Steeber DA, Harland RC, Tedder TF, Clavien PA. P-selectin mediates reperfusion injury through neutrophil and platelet sequestration in the warm ischemic mouse liver. Hepatology 1999; 29: 1494-1502.
33. Jaeschke H, Farhood A, Fisher MA, Smith CW. Sequestration of neutrophils in the hepatic vasculature during endotoxemia is independent of beta 2 integrins and intercellular adhesion molecule-1. Shock 1996; 6: 351-356.
34. Vollmar B, Glasz J, Menger MD, Messmer K. Leukocytes contribute to hepatic ischemia/reperfusion injury via intercellular adhesion molecule-1-mediated venular adherence. Surgery 1995; 117: 195-200.
35. Jaeschke H, Farhood A, Bautista AP, Spolarics Z, Spitzer JJ, Smith CW. Functional inactivation of neutrophils with a Mac-1 (CD11b/CD18) monoclonal antibody protects against ischemia-reperfusion injury in rat liver. Hepatology 1993; 17: 915-923.
36. Nishimura Y, Takei Y, Kawano S, Goto M, Nagano K, Tsuji S et al. The F(ab′)2 fragment of an anti-ICAM-1 monoclonal antibody attenuates liver injury after orthotopic liver transplantation. Transplantation 1996; 61: 99-104.
37. Cutrn JC, Perrelli MG, Cavalieri B, Peralta C, Rosell Catafau J, Poli G. Microvascular dysfunction induced by reperfusion injury and protective effect of ischemic preconditioning. Free Radic Biol Med 2002; 33: 1200-1208.
38. Vollmar B, Glasz J, Leiderer R, Post S, Menger M. Hepatic microcirculatory perfusion failure is a determinant of liver dysfunction in warm ischemia-reperfusion. Am J Pathol 1994; 145: 1421-1431.
39. Mittal MK, Gupta TK, Lee FY, Sieber CC, Groszmann RJ. Nitric oxide modulates hepatic vascular tone in normal rat liver. Am J Physiol 1994; 267: G416-G422.
40. Zhang JX, Pegoli W Jr, Clemens MG. Endothelin-1 induces direct constriction of hepatic sinusoids. Am J Physiol 1994; 266: G624-G632.
41. Kawamura E, Yamanaka N, Okamoto E, Tomoda F, Furukawa K. Response of plasma and tissue endothelin-1 to liver ischemia and its implication in ischemia-reperfusion injury. Hepatology 1995; 21: 1138-1143.
42. Scommotau S, Uhlmann D, Loffler BM, Breu V, Spiegel HU. Involvement of endothelin/nitric oxide balance in hepatic ischemia/reperfusion injury. Langenbecks Arch Surg 1999; 384: 65-70.
43. Rockey DC, Chung JJ. Inducible nitric oxide synthase in rat hepatic lipocytes and the effect of nitric oxide on lipocyte contractility. J Clin Invest 1995; 95: 1199-1206.
44. Kawada N, Tran-Thi TA, Klein H, Decker K. The contraction of hepatic stellate (Ito) cells stimulated with vasoactive substances. Possible involvement of endothelin 1 and nitric oxide in the regulation of the sinusoidal tonus. Eur J Biochem 1993; 213: 815-823.
45. Housset CN, Rockey DC, Friedman SL, Bissell DM. Hepatic lipocytes: a major target for endothelin-1. J Hepatol 1995; 22(Suppl): 55-60.
46. McKeown CM, Edwards V, Phillips MJ, Harvey PR, Petrunka CN, Strasberg SM. Sinusoidal lining cell damage: the critical injury in cold preservation of liver allografts in the rat. Transplantation 1988; 46: 178-191.
47. Ikeda T, Yanaga K, Kishikawa K, Kakizoe S, Shimada M, Sugimachi K. Ischemic injury in liver transplantation: difference in injury sites between warm and cold ischemia in rats. Hepatology 1992; 16: 454-461.
48. Caldwell-Kenkel JC, Currin RT, Tanaka Y, Thurman RG, Lemasters JJ. Reperfusion injury to endothelial cells following cold ischemic storage of rat livers. Hepatology 1989; 10: 292-299.
49. Otto G, Wolff H, David H. Preservation damage in liver transplantation: electron-microscopic findings. Transplant Proc 1984; 16: 1247-1248.
50. Marzi I, Zhong Z, Lemasters JJ, Thurman RG. Evidence that graft survival is not related to parenchymal cell viability in rat liver transplantation. The importance of nonparenchymal cells. Transplantation 1989; 48: 463-468.
51. Huet PM, Nagaoka MR, Desbiens G, Tarrab E, Brault A, Bralet MP et al. Sinusoidal endothelial cell and hepatocyte death following cold ischemia-warm reperfusion of the rat liver. Hepatology 2004; 39: 1110-1119.
52. Kim JS, Qian T, Lemasters JJ. Mitochondrial permeability transition in the switch from necrotic to apoptotic cell death in ischemic rat hepatocytes. Gastroenterology 2003; 124: 494-503.
53. Kim JS, Ohshima S, Pediaditakis P, Lemasters JJ. Nitric oxide protects rat hepatocytes against reperfusion injury mediated by the mitochondrial permeability transition. Hepatology 2004; 39: 1533-1543.
54. Sasaki H, Matsuno T, Tanaka N, Orita K. Activation of apoptosis during the reperfusion phase after rat liver ischemia. Transplant Proc 1996; 28: 1908-1909.
55. Gao W, Bentley RC, Madden JF, Clavien PA. Apoptosis of sinusoidal endothelial cells is a critical mechanism of preservation injury in rat liver transplantation. Hepatology 1998; 27: 1652-1660.
56. Kohli V, Selzner M, Madden JF, Bentley RC, Clavien PA. Endothelial cell and hepatocyte deaths occur by apoptosis after ischemia-reperfusion injury in the rat liver. Transplantation 1999; 67: 1099-1105.
57. Gavrieli Y, Sherman Y, Ben-Sasson SA. Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J Cell Biol 1992; 119: 493-501.
58. Grasl-Kraupp B, Ruttkay-Nedecky B, Koudelka H, Bukowska K, Bursch W, Schulte-Hermann R. In situ detection of fragmented DNA (TUNEL assay) fails to discriminate among apoptosis, necrosis, and autolytic cell death: a cautionary note. Hepatology 1995; 21: 1465-1468.
59. Thornberry NA, Lazebnik Y. Caspases: enemies within. Science 1998; 281: 1312-1316.
60. Natori S, Selzner M, Valentino KL, Fritz LC, Srinivasan A, Clavien PA et al. Apoptosis of sinusoidal endothelial cells occurs during liver preservation injury by a caspase-dependent mechanism. Transplantation 1999; 68: 89-96.
61. Rentsch M, Beham A, Iesalnieks I, Mirwald T, Anthuber M, Jauch KW. Impact of prolonged cold ischemia and reperfusion on apoptosis, activation of caspase 3, and expression of bax after liver transplantation in the rat. Transplant Proc 2001; 33: 850-851.
62. Natori S, Higuchi H, Contreras P, Gores GJ. The caspase inhibitor IDN-6556 prevents caspase activation and apoptosis in sinusoidal endothelial cells during liver preservation injury. Liver Transpl 2003; 9: 278-284.
63. Cursio R, Gugenheim J, Ricci JE, Crenesse D, Rostagno P, Maulon L et al. A caspase inhibitor fully protects rats against lethal normothermic liver ischemia by inhibition of liver apoptosis. FASEB J 1999; 13: 253-261.
64. Gujral JS, Bucci TJ, Farhood A, Jaeschke H. Mechanism of cell death during warm hepatic ischemia-reperfusion in rats: apoptosis or necrosis? Hepatology 2001; 33: 397-405.
65. Jaeschke H. Reperfusion injury after warm ischemia or cold storage of the liver: role of apoptotic cell death. Transplant Proc 2002; 34: 2656-2658.
66. Jaeschke H, Lemasters JJ. Apoptosis versus oncotic necrosis in hepatic ischemia/reperfusion injury. Gastroenterology 2003; 125: 1246-1257.
67. Murry C, Jennings R, Reimer K. Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. Circulation 1986; 74: 1124-1136.
68. Selzner N, Rudiger H, Graf R, Clavien PA. Protective strategies against ischemic injury of the liver. Gastroenterology 2003; 125: 917-936.
69. Jenkins DP, Baxter GF, Yellon DM. The pathophysiology of ischaemic preconditioning. Pharmacol Res 1995; 31: 219-224.
70. Korthuis R, Gute D, Cepinskas G, Kvietys P. Cellular mechanisms of acute versus delayed preconditioning. Pathophysiology 1998; 5: 35-48.
71. Arai M, Thurman RG, Lemasters JJ. Ischemic preconditioning of rat livers against cold storage-reperfusion injury: role of nonparenchymal cells and the phenomenon of heterologous preconditioning. Liver Transpl 2001; 7: 292-299.
72. Ates E, Gene E, Erkasap N, Erkasap S, Akman S, Firat P et al. Renal protection by brief liver ischemia in rats. Transplantation 2002; 74: 1247-1251.
73. Verdouw PD, Gho BC, Koning MM, Schoemaker RG, Duncker DJ. Cardioprotection by ischemic and nonischemic myocardial stress and ischemia in remote organs. Implications for the concept of ischemic preconditioning. Ann N Y Acad Sci 1996; 793: 27-42.
74. Cavalieri B, Perrelli MG, Aragno M, Ramadori P, Poli G, Cutrin JC. Ischaemic preconditioning modulates the activity of Kupffer cells during in vivo reperfusion injury of rat liver. Cell Biochem Funct 2003; 21: 299-305.
75. Arai M, Thurman RG, Lemasters JJ. Involvement of Kupffer cells and sinusoidal endothelial cells in ischemic preconditioning to rat livers stored for transplantation. Transplant Proc 1999; 31: 425-427.
76. Schauer RJ, Gerbes AL, Vonier D, op den Winkel M, Fraunberger P, Bilzer M. Induction of cellular resistance against Kupffer cell-derived oxidant stress: a novel concept of hepatoprotection by ischemic preconditioning. Hepatology 2003; 37: 286-295.
77. Cavalieri B, Perrelli MG, Aragno M, Mastrocola R, Corvetti G, Durazzo M et al. Ischemic preconditioning attenuates the oxidant-dependent mechanisms of reperfusion cell damage and death in rat liver. Liver Transpl 2002; 8: 990-999.
78. Peralta C, Perales JC, Bartrons R, Mitchell C, Gilgenkrantz H, Xaus C et al. The combination of ischemic preconditioning and liver Bcl-2 overexpression is a suitable strategy to prevent liver and lung damage after hepatic ischemia-reperfusion. Am J Pathol 2002; 160: 2111-2122.
79. Peralta C, Prats N, Xaus C, Gelpi E, Rosello-Catafau J. Protective effect of liver ischemic preconditioning on liver and lung injury induced by hepatic ischemia-reperfusion in the rat. Hepatology 1999; 30: 1481-1489.
80. Peralta C, Fernandez L, Panes J, Prats N, Sans M, Pique JM et al. Preconditioning protects against systemic disorders associated with hepatic ischemia-reperfusion through blockade of tumor necrosis factor-induced P-selectin up-regulation in the rat. Hepatology 2001; 33: 100-113.
81. Teoh N, Leclercq I, Pena AD, Farrell G. Low-dose TNF-alpha protects against hepatic ischemia-reperfusion injury in mice: implications for preconditioning. Hepatology 2003; 37: 118-128.
82. Teoh N, Field J, Sutton J, Farrell G. Dual role of tumor necrosis factor-alpha in hepatic ischemia-reperfusion injury: studies in tumor necrosis factor-alpha gene knockout mice. Hepatology 2004; 39: 412-421.
83. Sawaya DE Jr, Brown M, Minardi A, Bilton B, Burney D, Granger DN et al. The role of ischemic preconditioning in the recruitment of rolling and adherent leukocytes in hepatic venules after ischemia/reperrasion. J Surg Res 1999; 85: 163-170.
84. Howell JG, Zibari GB, Brown MF, Burney DL, Sawaya DE, Olinde JG et al. Both ischemic and pharmacological preconditioning decrease hepatic leukocyte/endothelial cell interactions. Transplantation 2000; 69: 300-303.
85. Zapletal C, Maksan SM, Lehmann T, Guenther L, Fallsehr C, Mehrabi A et al. Ischemic preconditioning improves liver microcirculation after ischemia/reperfusion. Transplant Proc 1999; 31: 3260-3262.
86. Vajdova K, Heinrich S, Tian Y, Graf R, Clavien PA. Ischemic preconditioning and intermittent clamping improve murine hepatic microcirculation and Kupffer cell function after ischemic injury. Liver Transpl 2004; 10: 520-528.
87. Peralta C, Hotter G, Closa D, Gelpi E, Bulbena O, Rosello-Catafau J. Protective effect of preconditioning on the injury associated to hepatic ischemia-reperfusion in the rat: role of nitric oxide and adenosine. Hepatology 1997; 25: 934-937.
88. Arai M, Thurman RG, Lemasters JJ. Contribution of adenosine A(2) receptors and cyclic adenosine monophosphate to protective ischemic preconditioning of sinusoidal endothelial cells against storage/reperfusion injury in rat livers. Hepatology 2000; 32: 297-302.
89. Peralta C, Hotter G, Closa D, Prats N, Xaus C, Gelpi E et al. The protective role of adenosine in inducing nitric oxide synthesis in rat liver ischemia preconditioning is mediated by activation of adenosine A2 receptors. Hepatology 1999; 29: 126-132.
90. Lochner A, Marais E, Du Toit E, Moolman J. Nitric oxide triggers classic ischemic preconditioning. Ann N Y Acad Sci 2002; 962: 402-414.
91. Rakhit RD, Edwards RJ, Marber MS. Nitric oxide, nitrates and ischaemic preconditioning. Cardiovasc Res 1999; 43: 621-627.
92. Shah V, Kamath PS. Nitric oxide in liver transplantation: pathobiology and clinical implications. Liver Transpl 2003; 9: 1-11.
93. Serracino-Inglott F, Virlos IT, Habib NA, Williamson RC, Mathie RT. Adenosine preconditioning attenuates hepatic reperfusion injury in the rat by preventing the down-regulation of endothelial nitric oxide synthase. BMC Gastroenterol 2002; 2: 22.
94. Takano H, Manchikalapudi S, Tang XL, Qiu Y, Rizvi A, Jadoon AK et al. Nitric oxide synthase is the mediator of late preconditioning against myocardial infarction in conscious rabbits. Circulation 1998; 98: 441-449.
95. Gong JP, Tu B, Wang W, Peng Y, Li SB, Yan LN. Protective effect of nitric oxide induced by ischemic preconditioning on reperfusion injury of rat liver graft. World J Gastroenterol 2004; 10: 73-76.
96. Lu X-S, Zhan Y-Q, Yang X-P. Expression and transcription of inducible nitric oxide synthase in the liver ischaemic preconditioning in rats. Bulletin of Hunan Medical University 2003; 28: 563-566.
97. Liu Y, Sato T, O'Rourke B, Marban E. Mitochondrial ATP-dependent potassium channels: novel effectors of cardioprotection? Circulation 1998; 97: 2463-2469.
98. Billiar TR, Curran RD, Harbrecht BG, Stadler J, Williams DL, Ochoa JB et al. Association between synthesis and release of cGMP and nitric oxide biosynthesis by hepatocytes. Am J Physiol 1992; 262: C1077-C1082.
99. Carini R, De Cesaris MG, Splendore R, Vay D, Domenicotti C, Nitti MP et al. Signal pathway involved in the development of hypoxic preconditioning in rat hepatocytes. Hepatology 2001; 33: 131-139.
100. Ricciardi R, Meyers WC, Schaffer BK, Kim RD, Shah SA, Wheeler SM et al. Protein kinase C inhibition abrogates hepatic ischemic preconditioning responses. J Surg Res 2001; 97: 144-149.
101. Simkhovich BZ, Przyklenk K, Kloner RA. Role of protein kinase C as a cellular mediator of ischemic preconditioning: a critical review. Cardiovasc Res 1998; 40: 9-22.
102. Carini R, Grazia De Cesaris M, Splendore R, Domenicotti C, Nitti MP, Pronzato MA et al. Signal pathway responsible for hepatocyte preconditioning by nitric oxide. Free Radic Biol Med 2003; 34: 1047-1055.
103. Harada N, Hatano E, Koizumi N, Nitta T, Yoshida M, Yamamoto N et al. Akt activation protects rat liver from ischemia/reperfusion injury. J Surg Res 2004; 121: 159-170.
104. Izuishi K, Fujiwara M, Hossain MA, Usuki H, Maeta H. Significance of phosphoinositide 3-kinase pathway on ischemic preconditioning followed by ischemia reperfusion in mice liver. Transplant Proc 2003; 35: 132-133.
105. Carini R, Grazia De Cesaris M, Splendore R, Baldanzi G, Nitti MP, Alchera E et al. Role of phosphatidylinositol 3-kinase in the development of hepatocyte preconditioning. Gastroenterology 2004; 127: 914-923.
106. Datta SR, Dudek H, Tao X, Masters S, Fu H, Gotoh Y et al. Akt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery. Cell 1997; 91: 231-241.
107. Dimmeler S, Fleming I, Fisslthaler B, Hermann C, Busse R, Zeiher AM. Activation of nitric oxide synthase in endothelial cells by Akt-dependent phosphorylation. Nature 1999; 399: 601-605.
108. Selzner N, Selzner M, Jochum W, Clavien PA. Ischemic preconditioning protects the steatotic mouse liver against reperfusion injury: an ATP dependent mechanism. J Hepatol 2003; 39: 55-61.
109. Peralta C, Bartrons R, Riera L, Manzano A, Xaus C, Gelpi E et al. Hepatic preconditioning preserves energy metabolism during sustained ischemia. Am J Physiol Gastrointest Liver Physiol 2000; 279: G163-G171.
110. Clavien PA, Selzner M, Rudiger HA, Graf R, Kadry Z, Rousson V et al. A prospective randomized study in 100 consecutive patients undergoing major liver resection with versus without ischemic preconditioning. Ann Surg 2003; 238: 843-850; discussion 851-842.
111. Teoh N, Dela Pena A, Farrell G. Hepatic ischemic preconditioning in mice is associated with activation of NF-kappaB, p38 kinase, and cell cycle entry. Hepatology 2002; 36: 94-102.
112. Steare SE, Yellon DM. The potential for endogenous myocardial antioxidants to protect the myocardium against ischaemia-reperfusion injury: refreshing the parts exogenous antioxidants cannot reach? J Mol Cell Cardiol 1995; 27: 65-74.
113. Kume M, Yamamoto Y, Saad S, Gomi T, Kimoto S, Shimabukuro T et al. Ischemic preconditioning of the liver in rats: implications of heat shock protein induction to increase tolerance of ischemia-reperfusion injury. J Lab Clin Med 1996; 128: 251-258.
114. Yin DP, Sankary HN, Chong AS, Ma LL, Shen J, Foster P et al. Protective effect of ischemic preconditioning on liver preservation-reperfusion injury in rats. Transplantation 1998; 66: 152-157.
115. Rudiger HA, Kang KJ, Sindram D, Riehle HM, Clavien PA. Comparison of ischemic preconditioning and intermittent and continuous inflow occlusion in the murine liver. Ann Surg 2002; 235: 400-407.
116. Clavien PA, Yadav S, Sindram D, Bentley RC. Protective effects of ischemic preconditioning for liver resection performed under inflow occlusion in humans. Ann Surg 2000; 232: 155-162.
117. Chouker A, Schachtner T, Schauer R, Dugas M, Lohe F, Martignoni A et al. Effects of Pringle manoeuvre and ischaemic preconditioning on haemodynamic stability in patients undergoing elective hepatectomy: a randomized trial. Br J Anaesth 2004; 93: 204-211.
118. Li SQ, Liang LJ, Huang JF, Li Z. Ischemic preconditioning protects liver from hepatectomy under hepatic inflow occlusion for hepatocellular carcinoma patients with cirrhosis. World J Gastroenterol 2004; 10: 2580-2584.
119. Nuzzo G, Giuliante F, Vellone M, De Cosmo G, Ardito F, Murazio M et al. Pedicle clamping with ischemic preconditioning in liver resection. Liver Transpl 2004; 10(Suppl 1): S53-S57.
120. Serafin A, Rosello-Catafau J, Prats N, Xaus C, Gelpi E, Peralta C. Ischemic preconditioning increases the tolerance of fatty liver to hepatic ischemia-reperfusion injury in the rat. Am J Pathol 2002; 161: 587-601.
121. Fernandez L, Carrasco-Chaumel E, Serafin A, Xaus C, Grande L, Rimola A et al. Is ischemic preconditioning a useful strategy in steatotic liver transplantation? Am J Transplant 2004; 4: 888-899.
122. Totsuka E, Fung JJ, Urakami A, Moras N, Ishii T, Takahashi K et al. Influence of donor cardiopulmonary arrest in human liver transplantation: possible role of ischemic preconditioning. Hepatology 2000; 31: 577-580.
123. Wilson DJ, Fisher A, Das K, Goerlitz F, Holland BK, De La Torre AN et al. Donors with cardiac arrest: improved organ recovery but no preconditioning benefit in liver allografts. Transplantation 2003; 75: 1683-1687.